Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial
Authors:
- Joseph A. CrawleyJCJoseph A. Crawley
- Kurt A. BrownKBKurt A. Brown
- 1 September 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 100 (9) , 1914-1922
Abstract
Sleep disturbances are common in patients with gastroesophageal reflux disease (GERD). This study examined the effects of esomeprazole on nighttime heartburn, GERD-related sleep disturbances, sleep quality, work productivity, and regular activities. This multicenter, randomized, double-blind, placebo-controlled trial included adults with GERD-associated sleep disturbances and moderate-to-severe nighttime heartburn (recorded by patient diary during screening). Patients received oral esomeprazole 40 mg (n = 220) or 20 mg (n = 226) or placebo (n = 229) once daily for 4 wk. The primary outcome was relief of nighttime heartburn. Secondary outcomes included resolution of sleep disturbances, sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaire, and work productivity measured by the Work Productivity and Activity Impairment Questionnaire. Nighttime heartburn was relieved in 53.1% (111/209), 50.5% (111/220), and 12.7% (28/221) of patients who received esomeprazole 40 mg, esomeprazole 20 mg, and placebo, respectively. Differences (95% CI) versus placebo were 40.5% (32.4%, 48.5%) and 37.8% (29.9%, 45.7%) and were highly significant (p < 0.0001). GERD-related sleep disturbances resolved in significantly more (p < 0.0001) patients who received esomeprazole 40 (73.7%) or 20 mg (73.2%) than in those who received placebo (41.2%). Both esomeprazole groups had greater PSQI global score changes from baseline (p < 0.0001 vs placebo) and more (p < 0.0001 vs placebo) work hours saved per week per patient compared with baseline (esomeprazole 40 mg, 11.6 h; esomeprazole 20 mg, 12.3 h; placebo, 6.2 h). Esomeprazole reduced nighttime heartburn and GERD-related sleep disturbances and improved sleep quality and work productivity.Keywords
This publication has 17 references indexed in Scilit:
- Sleep dysfunction in patients with gastro‐oesophageal reflux disease: prevalence and response to GERD therapy, a pilot studyAlimentary Pharmacology & Therapeutics, 2004
- Nighttime Heartburn Is An Under-Appreciated Clinical Problem That Impacts Sleep and Daytime Function: The Results of A Gallup Survey Conducted on Behalf of The American Gastroenterological AssociationAmerican Journal of Gastroenterology, 2003
- The burden of illness of gastro‐oesophageal reflux disease: impact on work productivityAlimentary Pharmacology & Therapeutics, 2003
- Health-Related Quality-of-Life and Quality-Days Incrementally Gained in Symptomatic Nonerosive GERD Patients Treated with Lansoprazole or RanitidineDigestive Diseases and Sciences, 2001
- The Impact of Nocturnal Symptoms Associated With Gastroesophageal Reflux Disease on Health-Related Quality of LifeArchives of internal medicine (1960), 2001
- Health-Related Quality of Life Outcomes of Omeprazole versus Ranitidine in Poorly Responsive Symptomatic Gastroesophageal Reflux DiseaseDigestive Diseases, 1998
- TYPICAL AND ATYPICAL PRESENTATIONS OF GASTROESOPHAGEAL REFLUX DISEASEGastroenterology Clinics of North America, 1996
- Epidemiology and Natural History of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis.Gut, 1991
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989